This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Cancer Related Fatigue in Patients Receiving Chemotherapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by Medical Center Alkmaar.
Recruitment status was:  Active, not recruiting
Information provided by:
Medical Center Alkmaar Identifier:
First received: December 1, 2005
Last updated: September 13, 2006
Last verified: September 2006
The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.

Cancer Fatigue

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments

Resource links provided by NLM:

Further study details as provided by Medical Center Alkmaar:

Estimated Enrollment: 90
Study Start Date: January 2006
Estimated Study Completion Date: July 2006

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of cancer requiring chemotherapy treatment

Exclusion Criteria:

  • Pregnancy
  • Psychological illness
  • Life expectancy less than three months
  • Lack of basic proficiency in Dutch
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00261534

Medical Centre Alkmaar
Alkmaar, Noord-Holland, Netherlands, 1815JD
Sponsors and Collaborators
Medical Center Alkmaar
Study Director: D. Hilarius, MSc Medical Centre Alkmaar, Hospital Pharmacy
  More Information Identifier: NCT00261534     History of Changes
Other Study ID Numbers: M05-057
Study First Received: December 1, 2005
Last Updated: September 13, 2006

Keywords provided by Medical Center Alkmaar:

Additional relevant MeSH terms:
Signs and Symptoms processed this record on August 16, 2017